CHTP

4:54 pm Chelsea Therapeutics confirms FDA accelerated approval of NORTHERA (droxidopa) for the treatment of symptomatic NOH (stock halted)

moreView todays social media effects on CHTPView the latest stocks trending across Twitter. Click to view dashboardSee who Chelsea is hiring next, click here to view […]

Chelsea Therapeutics Announces FDA Accelerated Approval of NORTHERAâ„¢ (Droxidopa) for the Treatment of Symptomatic NOH

[Business Wire] – Chelsea Therapeutics International, Ltd. today announced that the U.S. Food and Drug Administration granted accelerated approval of NORTHERATM for the treatment of symptomatic neurogenic orthostatic hypotension . moreView todays social media effects on CHTPView the latest stocks trending across Twitter. Click to view dashboardSee who Chelsea is hiring next, click here to view […]

Chelsea Therapeutics Wins FDA Approval For Northera

moreView todays social media effects on CHTPView the latest stocks trending across Twitter. Click to view dashboardSee who Chelsea is hiring next, click here to view […]

Chelsea Therapeutics Issues Statement Regarding Postponement of NORTHERA(TM) (Droxidopa) NDA PDUFA Action Date Due to Severe Weather

[GlobeNewswire] – CHARLOTTE, N.C. — Chelsea Therapeutics International, Ltd. today issued the following statement regarding the U.S. Food and Drug Administration (FDA) Prescription Drug User Fee Act (PDUFA) action date … moreView todays social media effects on CHTPView the latest stocks trending across Twitter. Click to view dashboardSee who Chelsea is hiring next, click here to view […]